1-179575708-TC-TCC
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PVS1PM2
The NM_014625.4(NPHS2):c.156dupG(p.Thr53AspfsTer17) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000071 in 1,407,972 control chromosomes in the GnomAD database, with no homozygous occurrence. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Synonymous variant affecting the same amino acid position (i.e. G52G) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_014625.4 frameshift
Scores
Clinical Significance
Conservation
Publications
- nephrotic syndrome, type 2Inheritance: AR, AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Myriad Women’s Health, Ambry Genetics, Labcorp Genetics (formerly Invitae), Illumina, G2P
- familial idiopathic steroid-resistant nephrotic syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| NPHS2 | ENST00000367615.9 | c.156dupG | p.Thr53AspfsTer17 | frameshift_variant | Exon 1 of 8 | 1 | NM_014625.4 | ENSP00000356587.4 | ||
| NPHS2 | ENST00000367616.4 | c.156dupG | p.Thr53AspfsTer17 | frameshift_variant | Exon 1 of 7 | 1 | ENSP00000356588.4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 7.10e-7 AC: 1AN: 1407972Hom.: 0 Cov.: 31 AF XY: 0.00000143 AC XY: 1AN XY: 696962 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at